EVAR – preliminary results from a single-center experience of a Mediterranean city: case report

Abstract

Abdominal aortic aneurysm prevalence is estimated between 4 and 8% in screening programs, predominantly in males. The risk of rupture is directly proportionate to the size of the aneurysm; thus, prophylactic repair is justifiable. The three chief randomized trials comparing Endovascular Aneurysm Repair (EVAR) with conventional repair of abdominal aortic aneurysm have all shown a benefit of EVAR with respect to 30-day operative mortality and these results have been reinforced by data from large registries. Therefore, endovascular repair is now a common treatment option that offers a less-invasive alternative to standard surgical repair with the likely reduced hospitalization, morbidity, and mortality. In this work, we report the short-term results of six cases treated by Thoracic Endovascular Aneurysm Repair (TEVAR)/EVAR at Alexandria Vascular Center.